Abstract
Real-world data on the clinical and economic impact of switching from cigarettes to non-combustible (NC) tobacco products are lacking. This study describes select clinical outcomes and healthcare costs among adult males who continued to use combustible cigarettes (CS), switched to non-combustible smokeless products (ST), or quit tobacco (NT).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
